Refocused Gambro plans dialyser production ramp-up
This article was originally published in Clinica
Executive Summary
Following the announcement that it is to sell its US renal care service arm to DaVita, Sweden's Gambro has revealed plans to open a major new manufacturing site in North America. The decision to step up production capacity for synthetic dialysers reflects growing market demand for these devices over non-synthetic ones, as well as DaVita's commitment to source the majority of its dialysis products from Gambro for at least 10 years.